We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

135 hedge funds and large institutions have $262M invested in Immunogen Inc in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $137M → $262M (+$125M)

5% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 40

13% less funds holding

Funds holding: 156 → 135 (-21)

30% less call options, than puts

Call options by funds: $760K | Put options by funds: $1.09M

44% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 32

Holders
135
Holders Change
-21
Holders Change %
-13.46%
% of All Funds
3.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
38
Reduced
40
Closed
32
Calls
$760K
Puts
$1.09M
Net Calls
-$329K
Net Calls Change
+$160K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.6M
2
RG
Redmile Group
California
+$11.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$2.58M
4
Ameriprise
Ameriprise
Minnesota
+$1.15M
5
SSA
Schonfeld Strategic Advisors
New York
+$730K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.24M
2
Primecap Management
Primecap Management
California
-$3.17M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.93M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.29M
5
Two Sigma Investments
Two Sigma Investments
New York
-$708K
Name Holding Trade Value Shares
Change 		Change in
Stake
JMPWA
76
JP Morgan Private Wealth Advisors
California
$75K -$946 -324 -2%
VKH
77
Virtu KCG Holdings
New York
$74K -$344K -117,994 -86%
Comerica Bank
78
Comerica Bank
Texas
$74K – – –
GW
79
GW & Wade
Massachusetts
$71K – – –
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
$68K -$6.58K -2,253 -11%
RFCA
81
R&F Capital Advisors
New York
$68K +$51.5K +17,649 New
HighTower Advisors
82
HighTower Advisors
Illinois
$66K +$9.6K +3,289 +24%
Bessemer Group
83
Bessemer Group
New Jersey
$65K +$48.7K +16,678 New
WI
84
WrapManager Inc
California
$64K +$3.66K +1,253 +8%
Commonwealth Equity Services
85
Commonwealth Equity Services
Massachusetts
$61K +$6.34K +2,171 +16%
US Bancorp
86
US Bancorp
Minnesota
$59K +$44.7K +15,300 New
Principal Financial Group
87
Principal Financial Group
Iowa
$58K – – –
JCM
88
Jacobi Capital Management
Pennsylvania
$51K – – –
Invesco
89
Invesco
Georgia
$50K +$6.27K +2,149 +20%
OAM
90
Oppenheimer Asset Management
New York
$48K +$36.3K +12,438 New
ECM
91
ETrade Capital Management
Virginia
$46K +$34.9K +11,942 New
AG
92
Aperio Group
California
$45K +$33.8K +11,576 New
AB
93
Amalgamated Bank
New York
$40K +$6 +2 +0%
CG
94
Cutler Group
California
$39K -$14K -4,798 -32%
FDCDDQ
95
Federation des caisses Desjardins du Quebec
Quebec, Canada
$38.7K +$29.2K +10,000 New
Canada Life
96
Canada Life
Manitoba, Canada
$35K – – –
AG
97
Advisor Group
Arizona
$32K +$4.01K +1,374 +20%
MAM
98
Meeder Asset Management
Ohio
$26K -$27.5K -9,415 -58%
Fifth Third Bancorp
99
Fifth Third Bancorp
Ohio
$26K – – –
AIP
100
Ameritas Investment Partners
Nebraska
$26K +$19.4K +6,651 New
2 3
4
5 6

IMGN Hedge Fund Activity: Q1 2017 in Review

135 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2017, worth a combined $262M — up 91% from $137M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of IMGN and 18 opened new positions — a net loss of 14 holders — while 40 trimmed existing stakes and 38 added.

The largest buyer was BlackRock, adding an estimated $15.6M. The largest seller was Millennium Management, cutting an estimated $3.24M.

  • 135 institutional investors held Immunogen Inc (IMGN) as of Q1 2017, down from 156 in Q4 2016.
  • Funds reported $262M of Immunogen Inc stock for Q1 2017, up 91% quarter-over-quarter.
  • 18 funds opened new Immunogen Inc positions in Q1 2017 and 32 closed out, a net change of -14 holders.
  • The largest Immunogen Inc buyer in Q1 2017 was BlackRock, an estimated $15.6M added.
  • The largest Immunogen Inc seller in Q1 2017 was Millennium Management, an estimated $3.24M sold.

Based on aggregated 13F filings for Q1 2017.